hrp0098p1-266 | Growth and Syndromes 4 | ESPE2024

AFMS (Achondroplasia Foramen Magnum Score) in a case series; correlation with clinical manifestations, and sleep studies.

Hatziagapiou Kyriaki , Georgakopoulou Danai , Polytarchou Anastasia , Moudaki Aggeliki , Kanaka-Gantenbein Christina , D Sakka Sophia

Background: Achondroplasia (ACH) is an autosomal dominant condition, resulting from pathogenic missense FGFR3 (fibroblast-growth-factor receptor-3) variants. Foramen magnum stenosis (FMS) is a severe complication, with infants and younger children being at higher risk. FMS may be asymptomatic or cause cervical-medullary compression (CMC), presenting with hydrocephalus, hypotonia or hypertonia, central sleep apnea and sudden death. The scope of the stu...

hrp0098p2-134 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2024

Long-term follow-up of children and adolescents with congenital hyperinsulinism: a 16 years’ single center experience

Nikolaou Michaela , Georgakopoulou Danai , Anargyros Vasilakis Ioannis , Nicolaides Nicolas C , Binou Maria , Mertzanian Anny , Sertedaki Amalia , Kanaka Gantenbein Christina

Background/aim: Congenital hyperinsulinism (CHI) is a group of genetic disorders characterized by impaired insulin secretion, resulting in recurrent hypoglycemia. CHI is the most common cause of severe and persistent hypoglycemia in infancy and childhood that is associated with an increased risk of seizures, developmental delay and permanent brain damage, with lifelong neurodisability if treatment is delayed. The incidence of CHI is estimated to be approximate...